EP0057 in Combination With Olaparib in Advanced Ovarian Cancer 11 sites for NCT04669002 Fallopian Tube Endometrioid Adenocarcinoma, +5 more conditions NLG207, +1 more drug chemotherapy, +1 more type
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer 1 site for NCT02769962 Malignant Solid Tumor, +3 more conditions NLG207, +1 more drug chemotherapy, +1 more type